ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
ResMed's free cash flow for the twelve months ending Jun 30, 2026 was $1.65B, down 0.7% year over year. For fiscal 2026 it was $1.65B, down 0.7% from the year before. Over ten years it grew 12.9% a year on average. The highest annual figure on record is $1.66B in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.65B | -0.7% |
| FY2025 | Jun 30, 2025 | $1.66B | +27.6% |
| FY2024 | Jun 30, 2024 | $1.30B | +126.9% |
| FY2023 | Jun 30, 2023 | $573.63M | +165.2% |
| FY2022 | Jun 30, 2022 | $216.31M | -65.9% |
| FY2021 | Jun 30, 2021 | $634.01M | -10.3% |
| FY2020 | Jun 30, 2020 | $706.93M | +81.1% |
| FY2019 | Jun 30, 2019 | $390.34M | -11.8% |
| FY2018 | Jun 30, 2018 | $442.45M | +25.8% |
| FY2017 | Jun 30, 2017 | $351.83M | -28.1% |
| FY2016 | Jun 30, 2016 | $489.40M | +52.6% |
| FY2015 | Jun 30, 2015 | $320.68M | +0.7% |
| FY2014 | Jun 30, 2014 | $318.55M | -6.1% |
| FY2013 | Jun 30, 2013 | $339.24M | +1.0% |
| FY2012 | Jun 30, 2012 | $336.02M | +55.1% |
| FY2011 | Jun 30, 2011 | $216.58M | +64.9% |
| FY2010 | Jun 30, 2010 | $131.36M | +1.7% |
| FY2009 | Jun 30, 2009 | $129.19M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $403.50M | -20.6% |
| Q3 FY2026 | Mar 31, 2026 | $520.48M | -6.7% |
| Q2 FY2026 | Dec 31, 2025 | $311.21M | +8.1% |
| Q1 FY2026 | Sep 30, 2025 | $414.36M | +34.7% |
| Q4 FY2025 | Jun 30, 2025 | $508.18M | +22.4% |
| Q3 FY2025 | Mar 31, 2025 | $557.87M | +46.5% |
| Q2 FY2025 | Dec 31, 2024 | $287.98M | +15.4% |
| Q1 FY2025 | Sep 30, 2024 | $307.70M | +20.1% |
| Q4 FY2024 | Jun 30, 2024 | $415.23M | +104.6% |
| Q3 FY2024 | Mar 31, 2024 | $380.84M | +50.1% |
| Q2 FY2024 | Dec 31, 2023 | $249.48M | +146.3% |
| Q1 FY2024 | Sep 30, 2023 | $256.25M | +1542.0% |
| Q4 FY2023 | Jun 30, 2023 | $202.99M | +299.2% |
| Q3 FY2023 | Mar 31, 2023 | $253.75M | +267.8% |
| Q2 FY2023 | Dec 31, 2022 | $101.29M | -46.5% |
| Q1 FY2023 | Sep 30, 2022 | $15.61M | – |
| Q4 FY2022 | Jun 30, 2022 | $50.84M | -74.4% |
| Q3 FY2022 | Mar 31, 2022 | $68.99M | -59.4% |
| Q2 FY2022 | Dec 31, 2021 | $189.47M | +40.4% |
| Q1 FY2022 | Sep 30, 2021 | -$93.00M | -171.3% |
| Q4 FY2021 | Jun 30, 2021 | $198.62M | -36.4% |
| Q3 FY2021 | Mar 31, 2021 | $169.92M | -19.1% |
| Q2 FY2021 | Dec 31, 2020 | $134.97M | +201.1% |
| Q1 FY2021 | Sep 30, 2020 | $130.50M | -6.6% |
| Q4 FY2020 | Jun 30, 2020 | $312.30M | +161.1% |
| Q3 FY2020 | Mar 31, 2020 | $210.11M | +68.7% |
| Q2 FY2020 | Dec 31, 2019 | $44.83M | -59.6% |
| Q1 FY2020 | Sep 30, 2019 | $139.69M | +297.7% |
| Q4 FY2019 | Jun 30, 2019 | $119.62M | +7.0% |
| Q3 FY2019 | Mar 31, 2019 | $124.56M | -8.5% |
| Q2 FY2019 | Dec 31, 2018 | $111.04M | -4.8% |
| Q1 FY2019 | Sep 30, 2018 | $35.13M | -54.9% |
| Q4 FY2018 | Jun 30, 2018 | $111.80M | -8.3% |
| Q3 FY2018 | Mar 31, 2018 | $136.12M | +156.9% |
| Q2 FY2018 | Dec 31, 2017 | $116.58M | +10.8% |
| Q1 FY2018 | Sep 30, 2017 | $77.95M | +8.7% |
| Q4 FY2017 | Jun 30, 2017 | $121.95M | – |
| Q3 FY2017 | Mar 31, 2017 | $52.99M | – |
| Q2 FY2017 | Dec 31, 2016 | $105.21M | – |
| Q1 FY2017 | Sep 30, 2016 | $71.68M | – |